- Research works
- 57 ▲ 439% vs 2013–17
- Citations
- 557 9.8 per fractional work
- Top-10% rate
- 12.3% record average 16.5%
- Open access
- 44% world 28%
Not ranked overall: LUNGevity Foundation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 7.1×. Every wedge is a field page.
- Economics, Econometrics and Finance 7.1×
- Mathematics 4.3×
- Medicine 2.8×
- Health Professions 2.0×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Decision Sciences 0.7×
- Engineering 0.4×
- Earth and Planetary Sciences 0.4×
- Business, Management and Accounting 0.3×
- Social Sciences 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Psychology 0.2×
- Materials Science 0.2×
- Environmental Science 0.1×
- Immunology and Microbiology 0.1×
- Computer Science 0.1×
Who are the top researchers at LUNGevity Foundation?
Ranked on the composite score, Bellinda L. King‐Kallimanis and Upal Roy lead among researchers whose main affiliation is LUNGevity Foundation.
- 1 Bellinda L. King‐Kallimanis United States · #886,481 worldwide 30 citations · 23 works
- 2 Upal Roy United States · #1,480,910 worldwide 14 citations · 18 works
Which keywords describe research at LUNGevity Foundation?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Targeted Therapy, Cost of Care, Financial Toxicity, Chemotherapy, ALK Inhibitors, EGFR Mutations and Radiotherapy.
- Cancer Genomics
- Mortality Rates
- Population-Based Study
- False Discovery Rate
- Physical Activity
- Cancer Survivorship
- Anxiety
- CT Screening
- Adjuvant Therapy
- Radiotherapy
- ALK Inhibitors
- Financial Toxicity
- Targeted Therapy
- Clinical Trials
- Cost of Care
- Chemotherapy
- EGFR Mutations
- Quality of Life
- Biomarkers
- Lung Cancer
- Depression
- Patient-Reported Outcomes
- Adaptive Designs
- Cancer Incidence
- Global Surveillance
- Risk Factors
- Mutational Signatures
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 27 words, with their numbers
- Clinical Trials5▲ 27×6 topics
- Targeted Therapy5▲ 74×3 topics
- Cost of Care4▲ 412×1 topic
- Financial Toxicity4▲ 412×1 topic
- Chemotherapy3▲ 16×7 topics
- ALK Inhibitors3▲ 169×1 topic
- EGFR Mutations3▲ 169×1 topic
- Radiotherapy2▲ 23×2 topics
- Quality of Life2▲ 6.0×4 topics
- Adjuvant Therapy2▲ 60×2 topics
- Biomarkers2▲ 11×3 topics
- CT Screening2▲ 98×1 topic
- Lung Cancer2▲ 38×1 topic
- Anxiety2▲ 13×2 topics
- Depression2▲ 7.0×3 topics
- Cancer Survivorship2▲ 78×2 topics
- Patient-Reported Outcomes2▲ 102×1 topic
- Physical Activity2▲ 11×1 topic
- Adaptive Designs1▲ 243×1 topic
- False Discovery Rate1▲ 243×1 topic
- Cancer Incidence1▲ 35×3 topics
- Population-Based Study1▲ 68×2 topics
- Global Surveillance1▲ 92×1 topic
- Mortality Rates1▲ 44×1 topic
- Risk Factors1▲ 4.0×2 topics
- Cancer Genomics1▲ 52×1 topic
- Mutational Signatures1▲ 52×1 topic
Which research topics does LUNGevity Foundation publish most on?
By volume in 2022–2025: Economic and Financial Impacts of Cancer, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Cancer survivorship and care.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Economic and Financial Impacts of Cancer Economics and Econometrics 4 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 4 Cancer survivorship and care Oncology 2 works
- 5 Statistical Methods in Clinical Trials Statistics and Probability 1 works
- 6 Global Cancer Incidence and Screening Oncology 1 works
- 7 Cancer Genomics and Diagnostics Cancer Research 1 works
- 8 Ethics in Clinical Research Public Health, Environmental and Occupational Health 1 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 10 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has LUNGevity Foundation's research output changed?
Output in 2018–2022 was 439% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chicago
- University of Chicago
- University of Illinois Chicago
- Loyola University Chicago
- Rush University Medical Center
- Illinois Institute of Technology
- DePaul University
- Experimental Station
- Boeing (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.